Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Inhibitors targeting the DNA-binding domain of human STAT3 for treatment of metastatic cancers

Inhibitors targeting the DNA-binding domain of human STAT3 for treatment of metastatic cancers

US Patent 9382204 · Granted Jul 5, 2016

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Broadband decoupling radiating elements and base station antennas having such ra2025
Connection assembly for antenna and base station antenna2025
Compounds and methods to sensitize cancer cells to cisplatin2024
Survivin-targeting anti-tumor agents and uses thereof2024
D-amino acid oxidase mutants and uses thereof in preparing L-glufosinate2024
Compounds and methods to sensitize cancer cells to tyrosine kinase inhibitors2024
Multivalent glycan microarray platform2023
Combination drug therapy reduces PARP-1 related DNA repair and increases the eff2022
Method for collecting component model in component e-commerce platform2022
Multivalent glycan microarray platform2022
Survivin-targeting anti-tumor agents and uses thereof2019
Small molecule CMKLR1 antagonists in demyelinating disease2016